New patent for Pharmacyclics Llc drug IMBRUVICA

Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Llc and is included in three NDAs. It is available from one supplier. There are forty-one patents…

Source


Comments are closed.

Biotechblog